GlassScriptPhysician profile
James A Arceo
NPI 1821032566
$2,315.99
in general payments reported to CMS, 2019-2025
11 companies · $266 in 2025
The $266 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $74.15 · 2022: $323 · 2023: $207 · 2024: $1,446 · 2025: $266.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,102 · Travel and Lodging: $817.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,102.43 |
| Travel and Lodging | $816.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,779.13 | 2021-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Abbott Laboratories | $127.83 | 2021-2024 | Proclaim |
| Averitas Pharma INC. | $97.51 | 2023-2025 | Qutenza |
| Bioventus LLC | $86.11 | 2022-2024 | Durolane, Stimrouter Implantable Kit |
| Medtronic, INC. | $63.75 | 2024 | Activos 10 Bone Cement |
| Globus Medical, INC. | $33.74 | 2025 | Senza |
| Vertex Pharmaceuticals Incorporated | $29.79 | 2025 | |
| Nevro Corp. | $29.59 | 2022 | |
| Spr Therapeutics, INC | $25.97 | 2025 | Sprint Pns System |
| Grt US Holding, INC. | $21.57 | 2022 | |
| Hikma Pharmaceuticals USA | $21.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Arceo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.